mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |